Literature DB >> 31429161

Therapeutic effects of curcumin on sepsis and mechanisms of action: A systematic review of preclinical studies.

Arash Karimi1,2, Ramin Ghodsi1,2, Fateme Kooshki1,2, Mozhdeh Karimi3, Vahid Asghariazar1,4, Ali Tarighat-Esfanjani2.   

Abstract

Sepsis is a complex disease that begins with an infectious disorder and causes excessive immune responses. Curcumin is considered as an active component of turmeric that can improve the condition in sepsis due to its anti-inflammatory and antioxidant properties. PubMed, Embase, Google Scholar, Web of Science, and Scopus databases were searched. Searching was not limited to a specific publication period. Only English-language original articles, which had examined the effect of curcumin on sepsis, were included. At first, 1,098 articles were totally found, and 209 articles were selected after excluding duplicated data; 46 articles were remained due to the curcumin effects on sepsis. These included 23 in vitro studies and 23 animal studies. Our results showed that curcumin and various analogs of curcumin can have an inhibitory effect on sepsis-induced complications. Curcumin has the ability to inhibit the inflammatory, oxidative coagulation factors, and regulation of immune responses in sepsis. Despite the promising evidence of the therapeutic effects of curcumin on the sepsis complication, further studies seem necessary to investigate its effect and possible mechanisms of action in human studies.
© 2019 John Wiley & Sons, Ltd.

Entities:  

Keywords:  curcumin; immune response; inflammatory response; oxidative stress; sepsis

Mesh:

Substances:

Year:  2019        PMID: 31429161     DOI: 10.1002/ptr.6467

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  5 in total

Review 1.  Dietary phytonutrients and animal health: regulation of immune function during gastrointestinal infections.

Authors:  Andrew R Williams; Audrey I S Andersen-Civil; Ling Zhu; Alexandra Blanchard
Journal:  J Anim Sci       Date:  2020-04-01       Impact factor: 3.159

Review 2.  Anti-Hyperglycemic Agents in the Adjuvant Treatment of Sepsis: Improving Intestinal Barrier Function.

Authors:  Yi-Feng Wang; Jia-Wei Li; Da-Peng Wang; Ke Jin; Jiao-Jie Hui; Hong-Yang Xu
Journal:  Drug Des Devel Ther       Date:  2022-06-04       Impact factor: 4.319

Review 3.  Antiviral and immunomodulatory activity of curcumin: A case for prophylactic therapy for COVID-19.

Authors:  Rajesh K Thimmulappa; Kiran Kumar Mudnakudu-Nagaraju; Chandan Shivamallu; K J Thirumalai Subramaniam; Arun Radhakrishnan; Suresh Bhojraj; Gowthamarajan Kuppusamy
Journal:  Heliyon       Date:  2021-02-22

4.  Oral Co-Supplementation of Curcumin, Quercetin, and Vitamin D3 as an Adjuvant Therapy for Mild to Moderate Symptoms of COVID-19-Results From a Pilot Open-Label, Randomized Controlled Trial.

Authors:  Amjad Khan; Somia Iqtadar; Sami Ullah Mumtaz; Michael Heinrich; Domingo A Pascual-Figal; Shona Livingstone; Sajid Abaidullah
Journal:  Front Pharmacol       Date:  2022-06-07       Impact factor: 5.988

Review 5.  Sepsis-induced AKI: From pathogenesis to therapeutic approaches.

Authors:  Fang-Fang He; Yu-Mei Wang; Yi-Yuan Chen; Wei Huang; Zi-Qi Li; Chun Zhang
Journal:  Front Pharmacol       Date:  2022-09-15       Impact factor: 5.988

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.